Cabaletta Bio Inc (CABA)
12.87
0.00 (0.00%)
USD |
NASDAQ |
May 07, 14:02
Cabaletta Bio Price to Book Value: 2.629 for May 7, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 2.629 |
| May 03, 2024 | 2.531 |
| May 02, 2024 | 2.574 |
| May 01, 2024 | 2.535 |
| April 30, 2024 | 2.174 |
| April 29, 2024 | 2.140 |
| April 26, 2024 | 2.249 |
| April 25, 2024 | 2.488 |
| April 24, 2024 | 2.647 |
| April 23, 2024 | 2.720 |
| April 22, 2024 | 2.720 |
| April 19, 2024 | 2.725 |
| April 18, 2024 | 2.853 |
| April 17, 2024 | 3.094 |
| April 16, 2024 | 3.327 |
| April 15, 2024 | 3.305 |
| April 12, 2024 | 3.478 |
| April 11, 2024 | 3.658 |
| April 10, 2024 | 3.648 |
| April 09, 2024 | 3.844 |
| April 08, 2024 | 3.684 |
| April 05, 2024 | 3.468 |
| April 04, 2024 | 3.290 |
| April 03, 2024 | 3.358 |
| April 02, 2024 | 3.368 |
| Date | Value |
|---|---|
| April 01, 2024 | 3.435 |
| March 28, 2024 | 3.484 |
| March 27, 2024 | 3.503 |
| March 26, 2024 | 3.464 |
| March 25, 2024 | 3.429 |
| March 22, 2024 | 3.544 |
| March 21, 2024 | 3.582 |
| March 20, 2024 | 3.701 |
| March 19, 2024 | 3.676 |
| March 18, 2024 | 3.672 |
| March 15, 2024 | 3.828 |
| March 14, 2024 | 3.723 |
| March 13, 2024 | 3.974 |
| March 12, 2024 | 4.066 |
| March 11, 2024 | 4.002 |
| March 08, 2024 | 4.412 |
| March 07, 2024 | 4.387 |
| March 06, 2024 | 4.430 |
| March 05, 2024 | 4.257 |
| March 04, 2024 | 4.314 |
| March 01, 2024 | 4.707 |
| February 29, 2024 | 4.493 |
| February 28, 2024 | 4.526 |
| February 27, 2024 | 4.775 |
| February 26, 2024 | 4.622 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1911
Minimum
Sep 23 2022
6.220
Maximum
Dec 27 2023
2.350
Average
2.493
Median
Jan 13 2020
Price to Book Value Benchmarks
| Editas Medicine Inc | 1.326 |
| Regeneron Pharmaceuticals Inc | 3.924 |
| Vertex Pharmaceuticals Inc | 6.014 |
| FibroGen Inc | -- |
| Deciphera Pharmaceuticals Inc | 5.842 |
Price to Book Value Related Metrics
| Price | 12.87 |
| Earnings Yield | -12.90% |
| Market Cap | 620.87M |